Logo
x

Search

Subscribe Now

Terns Pharmaceuticals

PharmaShots Weekly Snapshots (March 11 – March 15, 2024)

PharmaShots Weekly Snapshots (March 11 – March 15, 2024)

  • March 15, 2024
Terns Pharmaceuticals’ TERN-701 Receives the US FDA’s Orphan Drug Designation to Treat Chronic Myeloid Leukemia

Terns Pharmaceuticals’ TERN-701 Receives the US FDA’s Orphan Drug Designation to Treat Chronic Myeloid Leukemia

  • March 13, 2024
Terns Pharmaceuticals Reports P-IIa Trial (DUET) Results of TERN-501 for Non-Alcoholic Steatohepatitis

Terns Pharmaceuticals Reports P-IIa Trial (DUET) Results of TERN-501 for Non-Alcoholic Steatohepatitis

  • August 9, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.